Urgent Need for Second-Line HIV Treatment
Radhakrishnan and Abraham, Indian Medical Parliamentarians Forum
Urgent Need for Second-Line HIV Treatment
Radhakrishnan and Abraham, Indian Medical Parliamentarians Forum
Data Exclusivity – The Impact of Article 39.3 in India: A Practical Perspective
Using examples of medicines that are already on the market, and some which do not yet have marketing approval in India, we attempt to demonstrate how the current proposal of a three-year data exclusivity period would impact access to these medicines.
Learn more about how you can help build a more equitable system for all